IRENE study: Phase 2 study of Retifanlimab and the oncolytic virus pelareorep in metastatic triple negative breast cancer

George, Mridula et al, Previously presented at the 2021 San Antonio Breast Cancer Symposium®; San Antonio, TX, USA